Humoral responses to tumour xenografts in ALS-treated mice.

Humoral responses to tumour xenografts in ALS-treated mice.

Pokaż inne wersje (1)

Opis bibliograficzny
Główni autorzy:	Beverley, P, Simpson, E
Format:	Journal article
Język:	English
Wydane:	1970

Podobne zapisy

HUMORAL RESPONSES TO TUMOUR XENOGRAFTS IN ALS-TREATED MICE
od: Beverley, P, i wsp.
Wydane: (1970)

Cell-mediated responses to tumour xenografts in mice.
od: Simpson, E, i wsp.
Wydane: (1972)

CELL-MEDIATED RESPONSES TO TUMOR XENOGRAFTS IN MICE
od: Simpson, E, i wsp.
Wydane: (1972)

The histological response to a xenogeneic tumour in mice.
od: Simpson, E, i wsp.
Wydane: (1973)

Metabolomic and transcriptomic response to imatinib treatment of gastrointestinal stromal tumour in xenograft-bearing mice
od: Szymon Macioszek, i wsp.
Wydane: (2023-04-01)

Cytotoxic activity in vitro of thymus-derived lymphocytes sensitized to xenograft antigens.
od: Beverley, P, i wsp.
Wydane: (1972)

CYTOTOXIC ACTIVITY IN-VITRO OF THYMUS-DERIVED LYMPHOCYTES SENSITIZED TO XENOGRAFT ANTIGENS
od: Beverley, P, i wsp.
Wydane: (1972)

Lymphocyte-dependent antibody in a tumor xenograft system.
od: Simpson, E, i wsp.
Wydane: (1973)

Oleuropein inhibits tumour growth and metastases dissemination in ovariectomised nude mice with MCF-7 human breast tumour xenografts
od: Maria Vittoria Sepporta, i wsp.
Wydane: (2014-05-01)

Soma-to-germline transmission of RNA in mice xenografted with human tumour cells: possible transport by exosomes.
od: Cristina Cossetti, i wsp.
Wydane: (2014-01-01)

Immune responses in mice to tumour challenge after immunization with Newcastle disease virus-infected or x-irradiated tumour cells or cell fractions.
od: Beverley, P, i wsp.
Wydane: (1973)

Establishment and Application of Patient-derived Tumour Xenograft Model
od: YIN Zhenyu, i wsp.
Wydane: (2020-11-01)

Colorectal carcinoma tumour budding and podia formation in the xenograft microenvironment.
od: Friedrich Prall, i wsp.
Wydane: (2017-01-01)

Raman spectroscopy and convolutional neural networks for monitoring biochemical radiation response in breast tumour xenografts
od: Alejandra M. Fuentes, i wsp.
Wydane: (2023-01-01)

Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response.
od: Thomas H P M Habets, i wsp.
Wydane: (2016-01-01)

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.
od: McLarty, K, i wsp.
Wydane: (2009)

Identification of Immunoreactive Tumour Antigens Using Free and Exosome-Associated Humoral Responses
od: Carolyn D. Roberson, i wsp.
Wydane: (2013-01-01)

Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer
od: David R. Pearce, i wsp.
Wydane: (2023-06-01)

Patient-derived mammosphere and xenograft tumour initiation correlates with progression to metastasis.
od: Eyre, R, i wsp.
Wydane: (2016)

Anti-tumour and radiosensitising effects of PARP inhibitor on cervical cancer xenografts
od: Qin Xue, i wsp.
Wydane: (2023-12-01)

Factors that influence response classifications in chemotherapy treated patient-derived xenografts (PDX)
od: Joan E. Malcolm, i wsp.
Wydane: (2019-03-01)

Effect of nabumetone on humoral immune responses in mice
od: Khalid Naveed, i wsp.
Wydane: (2020-07-01)

Establishment of Patient-Derived Xenografts in Mice
od: Dongkyoo Park, i wsp.
Wydane: (2016-11-01)

Macrophages enhance Vegfa-driven angiogenesis in an embryonic zebrafish tumour xenograft model
od: Denver D. Britto, i wsp.
Wydane: (2018-12-01)

Using Mice to Treat (Wo)men: Mining Genetic Changes in Patient Xenografts to Attack Breast Cancer
od: Steffi Oesterreich, i wsp.
Wydane: (2013-09-01)

The ameliorative effects of Averroha carambola on humoral response to sheep erythrocytes in non-treated and cyclophosphamide-immunocompromised mice
od: Shadma Wahab, i wsp.
Wydane: (2014-01-01)

Effects of ionizing radiation in combination with Erufosine on T98G glioblastoma xenograft tumours: a study in NMRI nu/nu mice
od: Henke Guido, i wsp.
Wydane: (2012-10-01)

Zebrafish tumour xenograft models: a prognostic approach to epithelial ovarian cancer
od: Gabriel Lindahl, i wsp.
Wydane: (2024-02-01)

Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts
od: Maurizio Callari, i wsp.
Wydane: (2018-01-01)

Blood vessel hyperpermeability and pathophysiology in human tumour xenograft models of breast cancer: a comparison of ectopic and orthotopic tumours
od: Ho Karyn S, i wsp.
Wydane: (2012-12-01)

In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model
od: Berend van der Wildt, i wsp.
Wydane: (2018-05-01)

Characterization of human cancer xenografts in humanized mice
od: Holly K Koblish, i wsp.
Wydane: (2020-05-01)

Tuning gut microbiota through a probiotic blend in gemcitabine‐treated pancreatic cancer xenografted mice
od: Concetta Panebianco, i wsp.
Wydane: (2021-11-01)

Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts
od: Chiara Agnoletto, i wsp.
Wydane: (2018-10-01)

Effect of adjuvants on the humoral immune response to congopain in mice and cattle
od: Kateregga John, i wsp.
Wydane: (2012-05-01)

Immunostaining Protocol: P-Stat3 (Xenograft and Mice)
od: Alexandre Calon, i wsp.
Wydane: (2014-05-01)

Immunostaining Protocol: P-Smad2 (Xenograft and Mice)
od: Alexandre Calon, i wsp.
Wydane: (2014-05-01)

Humoral and cellular immune response of mice challenged with Yersinia pestis antigenic preparations
od: Elida A. Leal, i wsp.
Wydane: (2017-11-01)

Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response
od: Feifei Zhang, i wsp.
Wydane: (2018-09-01)

Niclosamide Modulates the Cellular and Humoral Immune Response in Balb/c Mice
od: Bilal Mahmood Beg, i wsp.
Wydane: (2022-12-01)